◼ Archived
Health
Experimental pancreatic cancer vaccine shows promise in clinical trial
An investigational KRAS vaccine targeting pancreatic cancer has triggered a robust immune response in a phase 2 trial, positioning vaccines as a potential new frontier in KRAS-directed therapy.